Bank Julius Baer & Co. Ltd, Zurich Fusion Pharmaceuticals Inc. Transaction History

Bank Julius Baer & Co. Ltd, Zurich

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 09, 2022	SELL	$4.53 - $8.57 $9,060 - $17,140	-2,000 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$7.83 - $9.41 $156 - $188	20 Added 1.01%	2,000 $16,000
Q2 2021 Jul 23, 2021	BUY	$7.97 - $10.66 $15,780 - $21,106	1,980 New	1,980 $16,000

93K

1.4K

Ticker FUSN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,390,500
Description
Fusion Pharmaceuticals Inc., a clinical-stage oncology company, focuses on developing radiopharmaceuticals as precision medicines. The company has developed Targeted Alpha Therapies platform together with its proprietary Fast-Clear linker technology to enable us to connect alpha particle emitting isotopes to various targeting molecules in order ...

Get notified when there are updates to the investment portfolio of Bank Julius Baer & Co. Ltd, Zurich, based on Form 13F filings with the SEC.

Stay updated on Bank Julius Baer & Co. Ltd, Zurich with notifications on news.